3rd Quarter - Report

ASCENDIS PHARMA, LLC for ASCENDIS PHARMA, LLC

Firm
Client
Income
—
Expenses
$170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Rare disease / orphan drug policies. Medicare / Medicaid.

Foreign entity interest: Ascendis Pharma, LLC is wholly-owned by Ascendis Pharma A/S, and its interests in relation to these issues are similar to those of Ascendis Pharma, LLC.

LobbyistCovered position, as disclosed
KATHY KULKARNI Health Policy Aide/Legislative Director - Office of Congressman Frank Pallone Jr.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.